Marshall Urist's Insider Trades & SAST Disclosures
Marshall Urist's most recent trade in Royalty Pharma plc - Ordinary Shares - Class A was a trade of 2,182 LP interests in RPI US Partners 2019, LP done . Disclosure was reported to the exchange on Aug. 12, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Marshall Urist.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Royalty Pharma plc - Ordin... | Marshall Urist | EVP, Research & Investments | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Aug 2024 | 2,182 | 126,412 | - | - | LP interests in RPI US Partners 2019, LP | |
| Royalty Pharma plc - Ordin... | Marshall Urist | EVP, Research & Investments | Sale of securities on an exchange or to another person at price $ 37.30 per share. | 22 Feb 2023 | 23,333 | 46,667 | - | 37.3 | 870,239 | Class A Ordinary Shares |
| Royalty Pharma plc - Ordin... | Marshall Urist | EVP, Research & Investments | 17 Feb 2023 | 70,000 | 70,000 | - | 0 | Class A Ordinary Shares | ||
| Royalty Pharma plc - Ordin... | Marshall Urist | EVP, Research & Investments | 17 Feb 2023 | 7,000 | 128,594 | - | - | LP interests in RPI US Partners 2019, LP | ||
| Royalty Pharma plc - Ordin... | Marshall Urist | EVP, Research & Investments | Sale of securities on an exchange or to another person at price $ 43.20 per share. | 25 Jul 2022 | 19,734 | 0 | - | 43.2 | 852,461 | Class A Ordinary Shares |
| Royalty Pharma plc - Ordin... | Marshall Urist | EVP, Research & Investments | Sale of securities on an exchange or to another person at price $ 43.05 per share. | 25 Jul 2022 | 3,600 | 19,734 | - | 43.1 | 154,985 | Class A Ordinary Shares |
| Royalty Pharma plc - Ordin... | Marshall Urist | EVP, Research & Investments | Sale of securities on an exchange or to another person at price $ 43.19 per share. | 24 Jun 2022 | 23,333 | 23,334 | - | 43.2 | 1,007,694 | Class A Ordinary Shares |
| Royalty Pharma plc - Ordin... | Marshall Urist | EVP, Research & Investments | Sale of securities on an exchange or to another person at price $ 39.85 per share. | 16 May 2022 | 23,333 | 46,667 | - | 39.9 | 929,836 | Class A Ordinary Shares |
| Royalty Pharma plc - Ordin... | Marshall Urist | EVP, Research & Investments | 11 May 2022 | 70,000 | 70,000 | - | 0 | Class A Ordinary Shares | ||
| Royalty Pharma plc - Ordin... | Marshall Urist | EVP, Research & Investments | 11 May 2022 | 7,000 | 205,594 | - | - | LP interests in RPI US Partners 2019, LP | ||
| Royalty Pharma plc - Ordin... | Marshall Urist | EVP & Co-Head of R&I | Sale of securities on an exchange or to another person at price $ 47.02 per share. | 04 Jun 2021 | 16,568 | 0 | - | 47.0 | 779,059 | Class A Ordinary Shares |
| Royalty Pharma plc - Ordin... | Marshall Urist | EVP & Co-Head of R&I | Sale of securities on an exchange or to another person at price $ 45.13 per share. | 04 Jun 2021 | 16,566 | 16,568 | - | 45.1 | 747,662 | Class A Ordinary Shares |
| Royalty Pharma plc - Ordin... | Marshall Urist | EVP & Co-Head Research & Inv. | Sale of securities on an exchange or to another person at price $ 41.52 per share. | 02 Jun 2021 | 14,566 | 33,134 | - | 41.5 | 604,850 | Class A Ordinary Shares |
| Royalty Pharma plc - Ordin... | Marshall Urist | EVP & Co-Head Research & Inv. | Sale of securities on an exchange or to another person at price $ 41.08 per share. | 20 May 2021 | 1,900 | 47,800 | - | 41.1 | 78,059 | Class A Ordinary Shares |
| Royalty Pharma plc - Ordin... | Marshall Urist | EVP & Co-Head Research & Inv. | Sale of securities on an exchange or to another person at price $ 41.00 per share. | 20 May 2021 | 100 | 47,700 | - | 41 | 4,100 | Class A Ordinary Shares |
| Royalty Pharma plc - Ordin... | Marshall Urist | EVP & Co-Head Research & Inv. | 07 May 2021 | 49,700 | 49,700 | - | 0 | Class A Ordinary Shares | ||
| Royalty Pharma plc - Ordin... | Marshall Urist | EVP & Co-Head Research & Inv. | 07 May 2021 | 4,970 | 142,594 | - | - | LP interests in RPI US Partners 2019, LP |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges